1. Role of lymph node dissection in managing urologic cancers

   • Tomonori Habuchi

   Introduction to Review Articles 07 April 2011 Pages: 169 - 169

2. The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract

   • Tsunenori Kondo
   • Kazunari Tanabe

   Review Article 21 April 2011 Pages: 170 - 178

   

3. Role of lymph node dissection in management of bladder cancer

   • Hiroshi Kitamura
   • Naoya Masumori
   • Taiji Tsukamoto

   Review Article 28 April 2011 Pages: 179 - 185

   

4. The role of lymph node dissection in renal cell carcinoma

   • Brian F. Chapin
   • Scott E. Delacroix Jr.
   • Christopher G. Wood

   Review Article 28 April 2011 Pages: 186 - 194

   

5. The role of lymph node dissection in the management of prostate cancer

   • Jun Miki
   • Shin Egawa

   Review Article 10 May 2011 Pages: 195 - 202

6. Metastasis of colorectal carcinoma to the testes: clinical presentation and possible pathways

   • Hassan A. Hatoum
   • George S. Abi Saad
   • Ali I. Shamseddine

   Review Article 11 November 2010 Pages: 203 - 209

   

7. Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

   • Hiroaki Hagihara
   • Kazuhiro Nouso
   • Kazuhide Yamamoto

   Original Article 09 December 2010 Pages: 210 - 220

   

8. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma

   • Kazuhiro Kasai
   • Akira Ushio
   • Kazuyuki Suzuki

   Original Article 04 December 2010 Pages: 221 - 229

   

9. A survey of disclosure of diagnosis to patients with glioma in Japan

   • Fukuko Yamamoto
   • Naoya Hashimoto
   • Toshiki Yoshimine

   Original Article 08 December 2010 Pages: 230 - 237

10. Risk factors for lower-limb lymphedema after surgery for cervical cancer

    • Yoko Ohba
    • Yukiharu Todo
    • Noriaki Sakuragi

    Original Article 07 January 2011 Pages: 238 - 243

    

11. High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

    • Yasuhiro Kidera
    • Taroh Satoh
    • Kazuhiko Nakagawa

    Original Article 18 January 2011 Pages: 244 - 249

12. Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer

    • Masahiro Sasaoka
    • Tomoyuki Futami

    Original Article 14 January 2011 Pages: 250 - 256

    

13. Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy

    • Kazuhiro Miura
    • Hiroshi Nakano
    • Junki Koike

    Original Article 18 January 2011 Pages: 257 - 263

    

14. Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer

    • Filippo Francini
    • Alessandra Pascucci
    • Roberto Petrioli

    Original Article 18 January 2011 Pages: 264 - 269

    

15. Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune–Albright syndrome

    • Kenshi Sakayama
    • Yoshifumi Sugawara
    • Atsushi Nakamura

    Case Report 29 September 2010 Pages: 270 - 274

    

16. Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor

    • Yoko Kyono
    • Tatsuya Takayama
    • Seiichiro Ozono

    Case Report 16 September 2010 Pages: 275 - 278

    

17. Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST

    • Carla Rameri Alexandre Silva de Azevedo
    • Tadeu Ferreira Paiva Jr.
    • Celso Abdon Lopes de Mello

    Case Report 05 October 2010 Pages: 279 - 283